Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma

Cytokine-induced killer cells (CIK) in combination with dendritic cells (DCs) have shown favorable outcomes in renal cell carcinoma (RCC), yet some patients exhibit recurrence or no response to this therapy. In a broader perspective, enhancing the antitumor response of DC-CIK cells may help to addre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ying, Wu, Xiaolong, Sharma, Amit, Weiher, Hans, Schmid, Matthias, Kristiansen, Glen, Schmidt-Wolf, Ingo G. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453234/
https://www.ncbi.nlm.nih.gov/pubmed/36091050
http://dx.doi.org/10.3389/fimmu.2022.925633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453234/
https://www.ncbi.nlm.nih.gov/pubmed/36091050
http://dx.doi.org/10.3389/fimmu.2022.925633

Ejemplares similares